Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing
| Autor: | Triner, D., Graf, R.P., Madison, R.W., Gjoerup, O., Tukachinsky, H., Ross, J.S., Quintanilha, J.C.F., Li, G., Cheng, H.H., Pritchard, C.C., Zurita, A.J., Qin, Q., Zhang, T., Agarwal, N., Reichert, Z.R., Mateo, J., Cieslik, M., Morgan, T.M. |
|---|---|
| Zdroj: | In ESMO Open September 2024 9(9) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|